Subfatin concentration decreases in acute coronary syndrome

We investigated the association of serum subfatin concentration and acute myocardial infarction (AMI) in patients with ST-elevation myocardial infarction (STEMI) and non-STEMI (NSTEMI). In this study, patients who presented with chest pain (STEMI, NSTEMI, or non-cardiac chest pain) were included, i.e. 49 patients with non-cardiac chest pain (control) and 66 patients hospitalised with AMI. In the AMI group, 35 patients had NSTEMI and 31 had STEMI. Serum subfatin concentrations were determined via enzyme-linked immunosorbent assay (ELISA). Descriptive data on the patients and their comorbidities were recorded, and subfatin concentrations were analysed. Subfatin concentrations were significantly different in the control, STEMI and NSTEMI groups (P = 0.002). In addition, subfatin concentrations were significantly lower in patients in the NSTEMI group than those in the control group (P < 0.001), but there was no significant difference between STEMI and the control group (P = 0.143). The receiver operating characteristic (ROC) analysis performed for differentiating the AMI and control groups found that subfatin had 64% sensitivity and 69% specificity, whereas troponin had 59% sensitivity and 95% specificity. In patients with AMI, the ROC analysis for differentiating NSTEMI from STEMI found that subfatin had 94% sensitivity and 41% specificity, while troponin had 65% sensitivity and 88% specificity. Subfatin concentrations were lower in patients without STEMI than in patients with STEMI. Subfatin concentration is associated with NSTEMI

Comparison of the impact of epigallocatechin gallate and ellagic acid in an experimental cataract model induced by sodium selenite

"AIM: To compare the potential protective effects of epi-gallocatechin gallate (EGCG) and ellagic acid (EA) in an experimental cataract model. METHODS: Twenty-eight Spraque-Dawley rat pups were assigned into four groups. All the rats, except for those in the control group, were injected subcutaneously sodium selenite to induce experimental cataract on the postpartum ninth day, and between 10th and 14th days. Rats in the sham, EGCG, and EA groups were intraperitoneally administered 50 mg/(kg·d) saline solution, 50 mg/(kg·d) EGCG and 200 mg/(kg·d) EA, respectively. The reduced glutathione (GSH) and malondialdehyde (MDA) levels, total antioxidant status (TAS) and total oxidant status (TOS) in lens supernatants were measured. RESULTS: The mean cataract gradings in EGCG and EA groups were found to be significantly lower than that in sham group (P<0.001). The mean GSH levels and TASs in EGCG and EA groups were significantly higher than that in sham group while mean MDA levels and TOSs in EGCG and EA groups were significantly lower than that in the sham group (P<0.001). CONCLUSION: EGCG and EA have protective effects on cataract development via the inhibition of oxidative stress.

BMI and adipocytokine changes in COPD exacerbation and stable COPD

COPD is described by progressive airflow restriction and recurrent acute exacerbations, which is caused by inflammatory response occurring in lungs as a result of chronic inhalation of harmful particles and gases. The study was designed to determine the link of interleukin-6 (IL-6), adiponectin and visfatin with BMI and oxidant/antioxidant balance in Chronic Obstructive Pulmonary Disease (COPD), a systemic disease. The study comprised control (n=20), patients with COPD (n=37) from the Chest Diseases Clinic of Firat University Hospital. The serum MDA, IL-6, Visfatin and Adiponectin levels were evaluated by ELISA. Also, Pulmonary Function Tests were done. There was no significant difference between control and patients with COPD in terms of sex and age averages. On the contrary, BMI levels were statistically significantly lower in COPD group compared to the controls. MDA and adiponectin levels were higher, IL-6 and visfatin levels were lower in COPD groups contrary to controls. It was thought that the level changes of these parameters (MDA, IL-6, visfatin and adiponectin) may be an important factor in the development of COPD and in monitoring the treatment of COPD-related diseases

BMI and adipocytokine changes in COPD exacerbation and stable COPD

472-477COPD is described by progressive airflow restriction and recurrent acute exacerbations, which is caused by inflammatory response occurring in lungs as a result of chronic inhalation of harmful particles and gases. The study was designed to determine the link of interleukin-6 (IL-6), adiponectin and visfatin with BMI and oxidant/antioxidant balance in Chronic Obstructive Pulmonary Disease (COPD), a systemic disease. The study comprised control (n=20), patients with COPD (n=37) from the Chest Diseases Clinic of Firat University Hospital. The serum MDA, IL-6, Visfatin and Adiponectin levels were evaluated by ELISA. Also, Pulmonary Function Tests were done. There was no significant difference between control and patients with COPD in terms of sex and age averages. On the contrary, BMI levels were statistically significantly lower in COPD group compared to the controls. MDA and adiponectin levels were higher, IL-6 and visfatin levels were lower in COPD groups contrary to controls. It was thought that the level changes of these parameters (MDA, IL-6, visfatin and adiponectin) may be an important factor in the development of COPD and in monitoring the treatment of COPD-related diseases

Clinical experiences in primary retroperitoneal tumors

Amaç: Bu çalışmada Selçuk Üniversitesi Tıp Fakültesi 2011-2013 tarihleri arasında Çocuk Onkoloji Anabilim Dalı’nda takipli ve Çocuk Cerrahisi Kliniğince opere edilen toplam 22 retroperitoneal tümörlü hastaların kayıtları retrospektif olarak değerlendirildi. Olgular ve Yöntem: Retroperitoneal tümör nedeniyle 2011-2013 arasında cerrahi girişim yapılan olgular geriye dönük olarak incelendi. Primer retroperitoneal tümörü kontrol altına alınan, başka uzak organ metastazı olmayan cerrahi tedavi uygulanan olgular çalışmaya dahil edildi. Yaş, cinsiyet, primer tanı anında tümör evresi, cerrahi tedavi yöntemi, patolojik tanı ve takip açısından olguların dosyaları retrospektif olarak değerlendirildi. Bulgular: Olgularımızın 9’u (%40) erkek, 13’ü (%60) kızdı. Ortalama yaş erkeklerde 71 ay (3-132), kızlarda 37 ay (6-204) idi. Histopatolojik olarak olguların 15 (%68)’i nöroblastom, 4’ü (%18.5) wilms tümörü, 1’i (%4.5) embriyonal rabdomyosarkom, 1’i (%4.5) berrak hücreli sarkom, 1’i (%4.5) malign sinir kılıfı tümörü olarak değerlendirildi. Tanı anında olguların 8’i (%36) evre I, 7’si (%32) Evre III, 7’si (%32) evre IV safhasındaydı. Sonuç: Olgularımızın %68’i nöroblastom olup, tanı anında hastaların %64’ü evre III ve evre IV idi. Anatomik lokalizasyonları nedeniyle ileri evrelere kadar sessiz tümörler olan retroperitoneal tümörlerin çoğu nöroblastomdur ve genellikle ileri evrelerde tanı alırlar.Objective: In this study, Selcuk University Faculty of Medicine between 2011 - 2013 follow-up at the Department of Pediatric Oncology and Pediatric Surgery clinic was operated by a total of 22 patients with retroperitoneal tumors were evaluated retrospectively . Patients and Method: Retroperitoneal tumors were evaluated retrospectively during 2011-2013. The cases treated with primary retroperitoneal tumor, surgical treatment without other distant organ metastasis were included in the study. The files of the cases were primary diagnosis in terms of age, sex, tumor stage at the time of diagnosis, surgical treatment method, pathological diagnosis and follow-up reviewed retrospectively. Results: 9 out of 22 cases (40%) male and 13 (60%) were female. Male mean age of 71 months ( 3-132 ) in the girls 37 months ( 6-204 ) . The histological results, 15 (68%) of neuroblastoma , 4 (18.5%) Wilms, 1 (4.5% ) Embryonal Rhabdomyosarcoma , 1 (4.5% ) Clear cell sarcoma , 1 (4.5% ) malignant nerve sheath tumors were evaluated . Eight of the cases (36%) were stage I, 7 (32%) were stage III, 7 (32%) stage IV. Conclusion: In conclusion, 68% of our cases were neuroblastoma and 64% of the patients were stage III and stage IV at the time of diagnosis. Retroperitoneal tumors are generally diagnosed in advanced stages. We think that this is due to the anatomical localizations and the silent as far as the clinically advanced stage

The Relationship between Th1/Th2 Balance and 1α, 25-Dihydroxyvitamin D3 in Patients with Allergic Rhinitis

Objective:With regard to the correlation between T helper1/T helper2 (Th1/Th2) cell balance and 1α,25-dihydroxyvitamin D3, active metabolite of vitamin D, we studied Th1/Th2 cell balance by measuring levels of the cytokines interleukin (IL)-4, IL-10 and interferon- gamma (IFN-γ), which are important for immune response of patients with allergic rhinitis.Methods:Thirty adult patients diagnosed with allergic rhinitis (study group) and 40 healthy volunteers (control group) are examined in the research. IFN-γ, IL-4, IL-10, and total immunoglobulin E (IgE) levels from serum samples and vitamin D3 levels from plasma were determined in all patients.Results:In IgE, IL-4, IL-10, IFN-γ, and 1α,25-dihydroxyvitamin D3 levels (p<0.05), a statistically noticeable difference was observed between the study and control group. The 1α,25-dihydroxyvitamin D3 levels in both groups were compared and a statistically significant difference between the 1α,25-dihydroxyvitamin D3 levels in the study group and that in the control group (p<0.05) was observed. There was a positive correlation between IFN-γ and vitamin D levels (p<0.05) in the study group, whereas IgE, IL-4, and IL-10 levels showed a negative correlation with vitamin D3 levels (p<0.05).Conclusion:In our study, 1α,25-dihydroxyvitamin D3 levels were associated with Th1/Th2 balance in allergic rhinitis, and a remarkable correlation was observed among vitamin D deficiency and allergy. These findings show that 1α,25-dihydroxyvitamin D3 may have a remarkable role in the severity and control of allergic disorders. In addition, further investigations are required to confirm how vitamin D should be used in allergic diseases. Furthermore, to reveal the exact mechanism of vitamin D on allergic diseases, further studies are required

Twelve-year trends in the prevalence and risk factors of diabetes and prediabetes in Turkish adults

There is concern about an emerging diabetes epidemic in Turkey. We aimed to determine the prevalence of diagnosed and undiagnosed diabetes, prediabetes and their 12-year trends and to identify risk factors for diabetes in the adult Turkish population. A cross-sectional, population-based survey, ‘TURDEP-II’ included 26,499 randomly sampled adults aged ≥ 20 years (response rate: 87 %). Fasting glucose and biochemical parameters were measured in all; then a OGTT was performed to identify diabetes and prediabetes in eligible participants. The prevalence of diabetes was 16.5 % (new 7.5 %), translating to 6.5 million adults with diabetes in Turkey. It was higher in women than men (p = 0.008). The age-standardized prevalence to the TURDEP-I population (performed in 1997–98) was 13.7 % (if same diagnostic definition was applied diabetes prevalence is calculated 11.4 %). The prevalence of isolated-IFG and impaired glucose tolerance (IGT), and combined prediabetes was 14.7, 7.9, and 8.2 %, respectively; and that of obesity 36 % and hypertension 31.4 %. Compared to TURDEP-I; the rate of increase for diabetes: 90 %, IGT: 106 %, obesity: 40 % and central obesity: 35 %, but hypertension decreased by 11 % during the last 12 years. In women age, waist, body mass index (BMI), hypertension, low education, and living environment; in men age, BMI, and hypertension were independently associated with an increased prevalence of diabetes. In women current smoking, and in men being single were associated with a reduced risk. These results from one of the largest nationally representative surveys carried out so far show that diabetes has rapidly become a major public health challenge in Turkey. The figures are alarming and underscore the urgent need for national programs to prevent diabetes, to manage the illness and thus prevent complications. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s10654-013-9771-5) contains supplementary material, which is available to authorized users

The relationship between the latency period, infection markers, and oxidant and antioxidant states in women with preterm premature rupture of membranes

WOS: 000414028200024PubMed ID: 28168638A major cause of perinatal morbidity and mortality has been reported to be preterm premature rupture of membranes (PPROM). Our objective was to evaluate oxidant-antioxidant balance, infection parameters, time interval between rupture of membranes and delivery (latency period), and the relationship among all these parameters. Seventy-five cases with PPROM between 24 and 34 gestational weeks were included in the study. A control group of 41 women who gave birth at term were considered as the control group. The relationship among maternal plasma total oxidative stress (TOS), malondialdehyde (MDA), total antioxidant status (TAS), leukocyte counts, CRP, vitamin C and E levels, gestational week, neonatal birthweight, and latency period was evaluated. In cases with PPROM, rupture occurred at an average of 29.4 gestational weeks and premature babies were born at an average of 31.6 gestational weeks. The mortality rate of babies born to PPROM women was 18.7% (14/75) died at or following birth. In the PPROM group, TOS, MDA, and leukocyte counts were found to be significantly higher compared to the control group (p < 0.001). Besides, a significant negative correlation was detected among the latency period, TOS, CRP, and leukocyte counts (p < 0.05). Appropriate treatment protocols that strengthen antioxidant defense systems and taking into consideration the signs of infection can decrease the incidence of PPROM and/or mortality rates of babies born to PPROM women.Department of Scientific Research ProjectsThis study was funded by the Department of Scientific Research Projects in our University